CN112375798A - Method for producing doramectin by microbial fermentation - Google Patents
Method for producing doramectin by microbial fermentation Download PDFInfo
- Publication number
- CN112375798A CN112375798A CN202011222671.4A CN202011222671A CN112375798A CN 112375798 A CN112375798 A CN 112375798A CN 202011222671 A CN202011222671 A CN 202011222671A CN 112375798 A CN112375798 A CN 112375798A
- Authority
- CN
- China
- Prior art keywords
- fermentation
- doramectin
- culture medium
- stage
- soybean
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 164
- 230000004151 fermentation Effects 0.000 title claims abstract description 164
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 title claims abstract description 47
- 229960003997 doramectin Drugs 0.000 title claims abstract description 47
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 25
- 230000000813 microbial effect Effects 0.000 title claims abstract description 10
- 239000001963 growth medium Substances 0.000 claims abstract description 42
- 239000000843 powder Substances 0.000 claims abstract description 32
- XTIVBOWLUYDHKE-UHFFFAOYSA-M sodium;cyclohexanecarboxylate Chemical compound [Na+].[O-]C(=O)C1CCCCC1 XTIVBOWLUYDHKE-UHFFFAOYSA-M 0.000 claims abstract description 29
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 28
- 239000002609 medium Substances 0.000 claims abstract description 22
- 230000006698 induction Effects 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 16
- 239000000654 additive Substances 0.000 claims abstract description 15
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000012343 cottonseed oil Nutrition 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 14
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 14
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 14
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 14
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims abstract description 12
- 238000011218 seed culture Methods 0.000 claims abstract description 12
- 229940083466 soybean lecithin Drugs 0.000 claims abstract description 12
- 229920002472 Starch Polymers 0.000 claims abstract description 11
- 239000008107 starch Substances 0.000 claims abstract description 11
- 235000019698 starch Nutrition 0.000 claims abstract description 11
- 239000004382 Amylase Substances 0.000 claims abstract description 9
- 102000013142 Amylases Human genes 0.000 claims abstract description 9
- 108010065511 Amylases Proteins 0.000 claims abstract description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 9
- 235000019418 amylase Nutrition 0.000 claims abstract description 9
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 8
- 239000011780 sodium chloride Substances 0.000 claims abstract description 8
- 235000019764 Soybean Meal Nutrition 0.000 claims abstract description 5
- 235000012054 meals Nutrition 0.000 claims abstract description 5
- 239000004455 soybean meal Substances 0.000 claims abstract description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims abstract description 3
- 229960003563 calcium carbonate Drugs 0.000 claims abstract description 3
- 235000010216 calcium carbonate Nutrition 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims abstract description 3
- 244000068988 Glycine max Species 0.000 claims description 36
- 235000010469 Glycine max Nutrition 0.000 claims description 36
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims description 22
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 22
- 235000008696 isoflavones Nutrition 0.000 claims description 22
- 239000005913 Maltodextrin Substances 0.000 claims description 14
- 229920002774 Maltodextrin Polymers 0.000 claims description 14
- 229940035034 maltodextrin Drugs 0.000 claims description 14
- 229920001817 Agar Polymers 0.000 claims description 5
- 229920002261 Corn starch Polymers 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000008272 agar Substances 0.000 claims description 5
- 239000008120 corn starch Substances 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 230000000996 additive effect Effects 0.000 claims description 4
- 235000003687 soy isoflavones Nutrition 0.000 claims description 3
- YKURLXMIEPPIPR-UHFFFAOYSA-M sodium cyclohexene-1-carboxylate Chemical compound C1(=CCCCC1)C(=O)[O-].[Na+] YKURLXMIEPPIPR-UHFFFAOYSA-M 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 241001468227 Streptomyces avermitilis Species 0.000 abstract description 11
- 230000024053 secondary metabolic process Effects 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 17
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 10
- 230000009469 supplementation Effects 0.000 description 9
- 238000012258 culturing Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000013589 supplement Substances 0.000 description 7
- VZFUCHSFHOYXIS-UHFFFAOYSA-N cycloheptane carboxylic acid Natural products OC(=O)C1CCCCCC1 VZFUCHSFHOYXIS-UHFFFAOYSA-N 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 3
- NZNMSOFKMUBTKW-UHFFFAOYSA-M cyclohexanecarboxylate Chemical compound [O-]C(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-M 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 description 1
- 239000005930 Spinosad Substances 0.000 description 1
- 229950008167 abamectin Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- -1 cyclic carboxylic acid Chemical class 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940014213 spinosad Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- UAXOELSVPTZZQG-UHFFFAOYSA-N tiglic acid Natural products CC(C)=C(C)C(O)=O UAXOELSVPTZZQG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention provides a method for producing doramectin by microbial fermentation, which relates to the technical field of fermentation and comprises the following steps: (1) inoculating the seed liquid cultured by the slant culture medium and the seed culture medium into a fermentation culture medium for fermentation culture; (2) adding fermentation induction additives at the early stage, the middle stage and the later stage of fermentation to obtain doramectin after the fermentation is finished; wherein, the fermentation medium comprises: starch, amylase, cottonseed meal, soybean meal, yeast powder, sodium chloride, light calcium carbonate, pantothenic acid, soybean lecithin, sodium cyclohexanecarboxylate and water. The method can effectively promote the secondary metabolism of the streptomyces avermitilis to produce the doramectin, and the titer of the obtained doramectin is high.
Description
Technical Field
The invention relates to the technical field of fermentation, in particular to a method for producing doramectin by microbial fermentation.
Background
Doramectin is a macrolide antiparasitic drug, and is an abamectin antibiotic prepared by fermenting a new streptomyces avermitilis strain which takes cyclicarboxydic acid as a precursor through gene recombination. The doramectin is a secondary metabolite of the streptomyces avermitilis, generally, a carbon source, a nitrogen source, temperature and the like can influence the fermentation production of the streptomyces avermitilis, the addition of a precursor substance, namely cyclohexanecarboxylic acid or a salt thereof, is very critical in the fermentation process, although the content of the precursor substance cannot influence the activity of the streptomyces avermitilis, the doramectin also becomes a doramectin production short plate when the content of the cyclohexanecarboxylic acid is low, and the doramectin has an inhibition effect on the metabolism of the streptomyces avermitilis when the content of the doramectin is high.
Chinese patent CN109576196A discloses a fermentation medium for producing doramectin and a production method of doramectin, wherein the fermentation medium comprises the following components: 100g/L of starch, 0.1-0.2g/L of amylase, 12-18g/L of soybean cake powder, 12-18g/L of cottonseed cake powder, 0.5-1.5g/L of yeast powder, 0.01-0.2g/L of 2, 2-methylbutyric acid and 0.2-0.4g/L of cyclohexanecarboxylic acid or sodium cyclohexanecarboxylate. The invention obviously improves the fermentation level of doramectin by improving the fermentation culture medium and the doramectin production method, the titer reaches 3545 mu g/ml after the fermentation is carried out for 370 hours, and the whole production process is simple and easy to operate and is beneficial to industrial production. However, the method is mainly researched for a fermentation medium, wherein the cyclohexanecarboxylic acid and other components are directly added and are not supplemented except sugar, so that the fermentation efficiency and the yield of doramectin are possibly influenced.
In view of the above problems, some researchers have recently studied ways of supplementing precursors, carbon sources, and nitrogen sources at different times to promote the production of doramectin. For example, chinese patent CN104651427B discloses a method for producing doramectin, which controls the production of doramectin by controlling the feeding time, frequency, etc. of cyclohexanecarboxylic acid or a salt thereof and a feeding sugar, and the resulting method is suitable for producing doramectin by fermentation in a 500L fermenter. However, the invention is optimized mainly by combining conventional materials with supplementary cases, and although the production of the doramectin can be promoted to a certain extent, the final yield can be expected, the short plate of the cyclic carboxylic acid or the salt thereof in the fermentation process is still difficult to overcome, and the average fermentation unit of the doramectin obtained is low.
Aiming at the problems of low fermentation level, low efficiency and the like of the existing doramectin production method, a production method of doramectin with high efficiency needs to be found urgently, and further, the production of doramectin by the secondary metabolism of streptomyces avermitilis is promoted.
Disclosure of Invention
Aiming at the problems in the prior art, the invention provides a method for producing doramectin by microbial fermentation. The method can effectively promote the secondary metabolism of the streptomyces avermitilis to produce the doramectin, and the titer of the obtained doramectin is higher.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
the invention provides a method for producing doramectin by microbial fermentation, which comprises the following steps:
(1) inoculating the seed liquid cultured by the slant culture medium and the seed culture medium into a fermentation culture medium for fermentation culture;
(2) adding fermentation induction additives at the early stage, the middle stage and the later stage of fermentation to obtain doramectin after the fermentation is finished;
the fermentation medium comprises: starch, amylase, cottonseed meal, soybean meal, yeast powder, sodium chloride, light calcium carbonate, pantothenic acid, soybean lecithin, sodium cyclohexanecarboxylate and water.
Further, the fermentation medium comprises: 120g/L of starch 110-.
Preferably, the fermentation medium comprises: 115g/L of starch, 0.1g/L of amylase, 15g/L of cottonseed cake powder, 12g/L of soybean cake powder, 1g/L of yeast powder, 2g/L of sodium chloride, 8g/L of light calcium carbonate, 0.001g/L of pantothenic acid, 3g/L of soybean lecithin, 0.1/L of sodium cyclohexanecarboxylate and the balance of water.
Further, the fermentation-inducing supplement comprises: sodium cyclohexenoate and soy isoflavones.
Further, the fermentation induction supplements supplemented at different fermentation periods are respectively (the unit of supplementation is specifically the relationship of the total amount of supplementation in the total amount of the culture medium):
and (3) fermentation early stage: 0.3-0.5g/L of sodium cyclohexanecarboxylate and 0.5-0.8g/L of soybean isoflavone;
in the middle stage of fermentation: 0.5-0.8g/L of sodium cyclohexanecarboxylate and 0.4-0.5g/L of soybean isoflavone;
and (3) in the later fermentation stage: 0.2-0.3g/L of sodium cyclohexanecarboxylate and 0.2-0.4g/L of soybean isoflavone.
Preferably, the fermentation induction supplements which are added at different fermentation periods are respectively:
and (3) fermentation early stage: 0.4g/L of sodium cyclohexanecarboxylate and 0.6g/L of soybean isoflavone;
in the middle stage of fermentation: 0.6g/L of sodium cyclohexanecarboxylate and 0.5g/L of soybean isoflavone;
and (3) in the later fermentation stage: 0.2g/L of sodium cyclohexanecarboxylate and 0.3g/L of soybean isoflavone.
Further, the fermentation induction additives added in the middle and later stages of fermentation also comprise maltodextrin, and the addition amount of the maltodextrin in the middle stage of fermentation is 10-12g/L, preferably 10 g/L; the addition amount of maltodextrin at the later stage of fermentation is 12-18g/L, preferably 15 g/L.
Further, when the early stage of fermentation is fermentation culture for 25-35h, the middle stage of fermentation is fermentation culture for 90-120h, and the late stage of fermentation is fermentation culture for 185-200 h. Preferably, when the early fermentation stage is fermentation culture for 30 hours, the middle fermentation stage is fermentation culture for 100 hours, and the late fermentation stage is fermentation culture for 190 hours.
Further, the culture conditions of the fermentation medium are as follows: the temperature of the tank is 25-30 ℃, the pressure of the tank is 0.03-0.05Mpa, and the air flow is 50-100m3The rotation speed is 80-120rpm, and the culture period is 256-262 h. Preferably, the culture conditions of the fermentation medium are: the temperature of the tank is 28 ℃, the pressure of the tank is 0.04Mpa, and the air flow is 80m3The rotation speed is 100rpm, and the culture period is 260 h.
Further, the weight ratio of pantothenic acid to soybean lecithin in the step (1) is 0.001-0.002: 3.
Further, the slant culture medium in the step (1) comprises, by weight, 1-3% of dew alcohol, 1-3% of soybean cake powder, 1-3% of agar and the balance of water.
Further, the seed culture medium in the step (1) comprises the following components in percentage by weight: 1-2% of corn starch, 0.3-0.4% of glucose, 1-2% of soybean cake powder, 1-2% of cottonseed cake powder and the balance of water.
Further, the culture conditions of the slant culture medium in the step (1) are specifically as follows: adjusting pH to 7, controlling temperature to 28-30 deg.C, culturing for 6-8 days.
Further, the culture conditions of the seed culture medium in the step (1) are specifically as follows: adjusting pH to 7, culturing at 28-30 deg.C for 40-45 hr at 250 r/min.
Further, the amount of inoculation of the fermentation medium was 10%.
The technical effects obtained by the invention are as follows:
the invention aims at the problem that the supplementation of the cyclohexanecarboxylate is carried out in different fermentation periods, so that the adverse effect of excessive or small addition of the cyclohexanecarboxylate on the production of the spinosad is avoided, and meanwhile, researches find that when the soybean isoflavone and the maltodextrin are supplemented together with the sodium cyclohexanecarboxylate in different fermentation periods, the action relationship between an induction fermentation culture medium and a doramectin precursor is effectively driven, the sugar source is supplemented to a certain extent, and meanwhile, related components in the fermentation culture medium, such as pantothenic acid and soybean lecithin, generate certain related influence on the pantothenic acid and the soybean lecithin, so that the secondary metabolite production is promoted.
Detailed Description
It is worth to be noted that the streptomyces avermitilis used in the present invention is a streptomyces avermitilis mutant conventionally used in the art, specifically, streptomyces avermitilis mutant ATCC 53568, and the rest of the raw materials are all common commercially available products, and thus the source thereof is not particularly limited.
Example 1
A method for producing doramectin by microbial fermentation comprises the following steps:
(1) inoculating a seed solution cultured by a slant culture medium and a seed culture medium into a fermentation culture medium for fermentation culture, wherein the inoculation amount of the fermentation culture medium is 10%;
(2) adding fermentation induction additives at the early stage, the middle stage and the later stage of fermentation to obtain doramectin after the fermentation is finished;
wherein, the fermentation medium comprises: 110g/L of starch, 0.08g/L of amylase, 14g/L of cottonseed meal, 8g/L of soybean meal, 0.5g/L of yeast powder, 1g/L of sodium chloride, 8g/L of light calcium carbonate, 0.001g/L of pantothenic acid, 2g/L of soybean lecithin, 0.1/L of sodium cyclohexanecarboxylate and the balance of water. The culture conditions of the fermentation medium are as follows: the temperature of the tank is 25 ℃, the pressure of the tank is 0.03Mpa, and the air flow is 50m3The rotation speed is 80rpm, and the culture period is 262 h.
The fermentation induction additives supplemented in different fermentation periods are respectively (the unit of supplementation is the relationship of the total supplementation amount in the total amount of the culture medium):
fermentation early stage (fermentation culture time of 25 h): 0.3g/L of sodium cyclohexanecarboxylate and 0.5g/L of soybean isoflavone;
middle fermentation stage (fermentation culture time of 90 h): 0.5g/L of sodium cyclohexanecarboxylate, 0.4g/L of soybean isoflavone and 10g/L of maltodextrin;
late fermentation (185 h fermentation culture): 0.2g/L of sodium cyclohexanecarboxylate, 0.2g/L of soybean isoflavone and 12g/L of maltodextrin.
The slant culture medium in the step (1) comprises, by weight, 1% of dew alcohol, 1% of soybean cake powder, 1% of agar and the balance of water. The culture conditions are specifically as follows: adjusting pH to 7, and culturing at 28 deg.C for 8 days. The seed culture medium comprises the following components in percentage by weight: 1% of corn starch, 0.3% of glucose, 1% of soybean cake powder, 1% of cottonseed cake powder and the balance of water. The culture conditions are specifically as follows: adjusting the pH value to 7, culturing at 28 deg.C for 45h at 250 r/min.
Example 2
A method for producing doramectin by microbial fermentation comprises the following steps:
(1) inoculating a seed solution cultured by a slant culture medium and a seed culture medium into a fermentation culture medium for fermentation culture, wherein the inoculation amount of the fermentation culture medium is 10%;
(2) adding fermentation induction additives at the early stage, the middle stage and the later stage of fermentation to obtain doramectin after the fermentation is finished;
wherein, the fermentation medium comprises: 120g/L of starch, 0.15g/L of amylase and cottonseed cake16g/L of powder, 15g/L of soybean cake powder, 1.5g/L of yeast powder, 3g/L of sodium chloride, 10g/L of light calcium carbonate, 0.002g/L of pantothenic acid, 5g/L of soybean lecithin, 0.2/L of sodium cyclohexanecarboxylate and the balance of water. The culture conditions of the fermentation medium are as follows: the temperature of the tank is 30 ℃, the pressure of the tank is 0.05Mpa, and the air flow is 100m3The rotation speed is 120rpm, and the culture period is 256 hours.
The fermentation induction additives supplemented in different fermentation periods are respectively (the unit of supplementation is the relationship of the total supplementation amount in the total amount of the culture medium):
fermentation early stage (fermentation culture time of 35 h): 0.5g/L of sodium cyclohexanecarboxylate and 0.8g/L of soybean isoflavone;
middle fermentation stage (fermentation culture time 120 h): 0.8g/L of sodium cyclohexanecarboxylate, 0.5g/L of soybean isoflavone and 12g/L of maltodextrin;
and in the later fermentation stage (during fermentation culture for 200 h): 0.3g/L of sodium cyclohexanecarboxylate, 0.4g/L of soybean isoflavone and 18g/L of maltodextrin.
The slant culture medium in the step (1) comprises 3% of dew alcohol, 3% of soybean cake powder, 3% of agar and the balance of water by weight percentage. The culture conditions are specifically as follows: adjusting pH to 7, and culturing at 30 deg.C for 6 days. The seed culture medium comprises the following components in percentage by weight: 2% of corn starch, 0.4% of glucose, 2% of soybean cake powder, 2% of cottonseed cake powder and the balance of water. The culture conditions are specifically as follows: adjusting pH to 7, culturing at 30 deg.C for 40h at 250 r/min.
Example 3
A method for producing doramectin by microbial fermentation comprises the following steps:
(1) inoculating a seed solution cultured by a slant culture medium and a seed culture medium into a fermentation culture medium for fermentation culture, wherein the inoculation amount of the fermentation culture medium is 10%;
(2) adding fermentation induction additives at the early stage, the middle stage and the later stage of fermentation to obtain doramectin after the fermentation is finished;
wherein, the fermentation medium comprises: 115g/L of starch, 0.1g/L of amylase, 15g/L of cottonseed cake powder, 12g/L of soybean cake powder, 1g/L of yeast powder, 2g/L of sodium chloride, 8g/L of light calcium carbonate, 0.001g/L of pantothenic acid, 3g/L of soybean lecithin, 0.1/L of sodium cyclohexanecarboxylate and the balance of water.The culture conditions of the fermentation medium are as follows: the temperature of the tank is 28 ℃, the pressure of the tank is 0.04Mpa, and the air flow is 80m3The rotation speed is 100rpm, and the culture period is 260 h.
The fermentation induction additives supplemented in different fermentation periods are respectively (the unit of supplementation is the relationship of the total supplementation amount in the total amount of the culture medium):
fermentation early stage (fermentation culture time of 30 h): 0.4g/L of sodium cyclohexanecarboxylate and 0.6g/L of soybean isoflavone;
middle fermentation stage (100 h fermentation culture): 0.6g/L of sodium cyclohexanecarboxylate, 0.5g/L of soybean isoflavone and 10g/L of maltodextrin;
and in the later fermentation stage (when the fermentation culture lasts for 190 h): 0.2g/L of sodium cyclohexanecarboxylate, 0.3g/L of soybean isoflavone and 15g/L of maltodextrin.
The slant culture medium in the step (1) comprises 2% of dew alcohol, 2% of soybean cake powder, 2% of agar and the balance of water by weight percentage. The culture conditions are specifically as follows: the pH was adjusted to 7 and the temperature was adjusted to 28 ℃ and the culture was carried out for 7 days. The seed culture medium comprises the following components in percentage by weight: 1.5% of corn starch, 0.3% of glucose, 1.5% of soybean cake powder, 1.5% of cottonseed cake powder and the balance of water. The culture conditions are specifically as follows: adjusting pH to 7, culturing at 28 deg.C for 42h at 250 r/min.
Comparative example 1
The only difference from example 3 is that the fermentation medium comprises: 100g/L of starch, 0.2g/L of amylase, 12g/L of cottonseed meal, 18g/L of soybean meal, 0.3g/L of yeast powder, 5g/L of sodium chloride, 6g/L of light calcium carbonate, 0.003g/L of pantothenic acid, 1g/L of soybean lecithin, 0.6/L of sodium cyclohexanecarboxylate and the balance of water.
Comparative example 2
The only difference from example 3 is that no fermentation inducing supplement was added.
Comparative example 3
The only difference from example 3 is that the fermentation-inducing supplement does not contain soy isoflavones.
Comparative example 4
The only difference from example 3 is that no pantothenic acid and no soya lecithin were added to the fermentation medium.
Comparative example 5
The only difference from example 3 is that the fermentation induction supplements were only fed in the early stages of fermentation, including: 1.2g/L of sodium cyclohexanecarboxylate, 1.4g/L of soybean isoflavone and 25g/L of maltodextrin.
The concentration of the antibiotic in the fermentation broth, called fermentation unit, is also called titer, and can measure the effective components and performance of the antibiotic, generally, the higher the total fermentation unit (product of fermentation unit and fermentation broth volume) is, the smaller the fixed cost for putting people on unit yield is, and the higher the economic benefit is, after the fermentation culture is finished, the fermentation broth is filtered by filter paper, and then the fermentation titer of doramectin in each embodiment and comparative example is measured and calculated, and table 1 is obtained.
TABLE 1
| Examples of the invention | Potency (mg/L) |
| Example 1 | 2107 |
| Example 2 | 2215 |
| Example 3 | 2239 |
| Comparative example 1 | 1903 |
| Comparative example 2 | 1430 |
| Comparative example 3 | 1894 |
| Comparative example 4 | 1975 |
| Comparative example 5 | 1658 |
As can be seen from Table 1, the titer of doramectin in 256-262h in the examples of the invention is 2107-2239mg/L, wherein the optimum value in example 3 is 2239 mg/L. The potency of doramectin in the comparative examples 1-5 is obviously lower than that of the example 3, wherein the influence of the content of the components of the fermentation culture medium on the production of doramectin can be known in the comparative example 1 and the example 3, the effect of the doramectin obtained finally is remarkably reduced because no fermentation induction additive is added in the comparative example 2, and the potency is relatively poor due to the fact that the fermentation induction additive is added in the comparative example 5, although the fermentation induction additive is added in the early stage of fermentation, the addition amount is the same as the addition amount of the whole period, and the critical effect of doramectin supplemented in the invention can be seen; when the fermentation induction supplement does not contain the soybean isoflavone, as shown in comparative example 3, the titer is relatively low, and the soybean isoflavone can effectively induce the driving property between the cyclohexanecarboxylate and the fermentation medium in the technical scheme of the invention. Comparative example 4, on the other hand, can show the effect on potency of key components in the fermentation medium of the present application, such as pantothenic acid and soya lecithin.
Finally, it should be noted that the above-mentioned contents are only used for illustrating the technical solutions of the present invention, and not for limiting the protection scope of the present invention, and that the simple modifications or equivalent substitutions of the technical solutions of the present invention by those of ordinary skill in the art can be made without departing from the spirit and scope of the technical solutions of the present invention.
Claims (10)
1. A method for producing doramectin by microbial fermentation is characterized in that: the method comprises the following steps:
(1) inoculating the seed liquid cultured by the slant culture medium and the seed culture medium into a fermentation culture medium for fermentation culture;
(2) adding fermentation induction additives at the early stage, the middle stage and the later stage of fermentation to obtain doramectin after the fermentation is finished;
the fermentation medium comprises: starch, amylase, cottonseed meal, soybean meal, yeast powder, sodium chloride, light calcium carbonate, pantothenic acid, soybean lecithin, sodium cyclohexanecarboxylate and water.
2. The method of claim 1, wherein: the fermentation medium comprises: 120g/L of starch 110-.
3. The method of claim 1, wherein: the fermentation induction additive comprises: sodium cyclohexenoate and soy isoflavones.
4. The method of claim 3, wherein: the fermentation induction additives supplemented in different fermentation periods are respectively as follows:
and (3) fermentation early stage: 0.3-0.5g/L of sodium cyclohexanecarboxylate and 0.5-0.8g/L of soybean isoflavone;
in the middle stage of fermentation: 0.5-0.8g/L of sodium cyclohexanecarboxylate and 0.4-0.5g/L of soybean isoflavone;
and (3) in the later fermentation stage: 0.2-0.3g/L of sodium cyclohexanecarboxylate and 0.2-0.4g/L of soybean isoflavone.
5. The method of claim 4, wherein: the fermentation induction supplementary agent added in the middle and later fermentation stages also comprises maltodextrin, the supplementary amount of the maltodextrin in the middle fermentation stage is 10-12g/L, and the supplementary amount of the maltodextrin in the later fermentation stage is 12-18 g/L.
6. The method of claim 1, wherein: the early fermentation period is 25-35h, the middle fermentation period is 90-120h, and the later fermentation period is 185-200 h.
7. The method of claim 1, wherein: the culture conditions of the fermentation culture medium are as follows: the temperature of the tank is 25-30 ℃, the pressure of the tank is 0.03-0.05Mpa, and the air flow is 50-100m3The rotation speed is 80-120rpm, and the culture period is 256-262 h.
8. The method of claim 1, wherein: the weight ratio of the pantothenic acid to the soybean lecithin in the step (1) is 0.001-0.002: 3.
9. The method of claim 1, wherein: the slant culture medium in the step (1) comprises, by weight, 1-3% of dew alcohol, 1-3% of soybean cake powder, 1-3% of agar and the balance of water.
10. The method of claim 1, wherein: the seed culture medium in the step (1) comprises the following components in percentage by weight: 1-2% of corn starch, 0.3-0.4% of glucose, 1-2% of soybean cake powder, 1-2% of cottonseed cake powder and the balance of water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011222671.4A CN112375798B (en) | 2020-11-05 | 2020-11-05 | Method for producing doramectin by microbial fermentation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011222671.4A CN112375798B (en) | 2020-11-05 | 2020-11-05 | Method for producing doramectin by microbial fermentation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112375798A true CN112375798A (en) | 2021-02-19 |
| CN112375798B CN112375798B (en) | 2022-03-11 |
Family
ID=74579356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011222671.4A Active CN112375798B (en) | 2020-11-05 | 2020-11-05 | Method for producing doramectin by microbial fermentation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112375798B (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104561180A (en) * | 2014-12-26 | 2015-04-29 | 宁夏泰瑞制药股份有限公司 | Culture mediums for producing doramectin through fermentation of mutant streptomyces avermitilis and material supplement method |
| CN104651427A (en) * | 2015-01-21 | 2015-05-27 | 丽珠集团新北江制药股份有限公司 | Method for preparing doramectin |
| CN108018324A (en) * | 2016-10-28 | 2018-05-11 | 北大方正集团有限公司 | A kind of fermentation medium for producing doractin and preparation method and application |
| CN108396045A (en) * | 2018-02-24 | 2018-08-14 | 湖北宏中药业股份有限公司 | A kind of high yield fermentation method for producing of doractin |
| CN109576196A (en) * | 2019-01-25 | 2019-04-05 | 北大方正集团有限公司 | A kind of production method of the fermentation medium for producing doractin and doractin |
-
2020
- 2020-11-05 CN CN202011222671.4A patent/CN112375798B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104561180A (en) * | 2014-12-26 | 2015-04-29 | 宁夏泰瑞制药股份有限公司 | Culture mediums for producing doramectin through fermentation of mutant streptomyces avermitilis and material supplement method |
| CN104651427A (en) * | 2015-01-21 | 2015-05-27 | 丽珠集团新北江制药股份有限公司 | Method for preparing doramectin |
| CN108018324A (en) * | 2016-10-28 | 2018-05-11 | 北大方正集团有限公司 | A kind of fermentation medium for producing doractin and preparation method and application |
| CN108396045A (en) * | 2018-02-24 | 2018-08-14 | 湖北宏中药业股份有限公司 | A kind of high yield fermentation method for producing of doractin |
| CN109576196A (en) * | 2019-01-25 | 2019-04-05 | 北大方正集团有限公司 | A kind of production method of the fermentation medium for producing doractin and doractin |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112375798B (en) | 2022-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2027280B1 (en) | Process for the preparation of polymyxin b employing (paeni)bacillus polymyxa | |
| CN117327747B (en) | Method for producing D-pantothenic acid by microbial fermentation | |
| CN112375798B (en) | Method for producing doramectin by microbial fermentation | |
| CN110283854B (en) | Fermentation medium, application thereof and method for preparing lycopene by utilizing Blakeslea trispora fermentation | |
| CN104651427A (en) | Method for preparing doramectin | |
| CN109321626B (en) | Culture medium for improving aureomycin yield and method for producing aureomycin | |
| US5409820A (en) | Process for the production of lovastatin using Coniothyrium fuckelii | |
| CN113832205A (en) | Fed-batch fermentation method for producing amphotericin B in fermentation tank | |
| CN114015604A (en) | Fermentation medium and method for producing pleocidin through fermentation | |
| EP0520027A1 (en) | Process for the production of natural long-chain alcohols | |
| CN107723325B (en) | Fermentation production method of doramectin based on pH control | |
| US6197560B1 (en) | Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid | |
| CN104404113A (en) | Supplemented medium of vancomycin and production method of vancomycin | |
| US6500651B1 (en) | Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid | |
| US2830934A (en) | Process for production of penicillin | |
| CN114990178B (en) | Method for improving quality of avilamycin fermentation liquor | |
| RU2302462C2 (en) | Method for citric acid production | |
| EP2287324A2 (en) | Fermentation processes with low concentrations of carbon- and nitrogen-containing nutrients | |
| CN109929890B (en) | Fermentation process of mycophenolic acid | |
| CN118813515A (en) | Monensin culture medium based on regulation and control of metabolic synthesis speed and culture process thereof | |
| JPH05244973A (en) | Actinomadura fibrosa sp. nov. nrrl18348 and production of polyether-based antibiotic from this strain | |
| CN118006713A (en) | Method for improving fermentation titer of tylosin | |
| KR950007222B1 (en) | Production of l-leucine by microorganism cultivation | |
| CN116536384A (en) | Method for improving kanamycin fermentation level | |
| KR0169061B1 (en) | A process for preparing xylitol by controlling fermenting condition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Guan Hui Inventor after: Zheng Jianxun Inventor after: Chang Junyi Inventor after: Zhou Yanle Inventor after: Ye Peng Inventor before: Zheng Jianxun Inventor before: Chang Junyi Inventor before: Zhou Yanle Inventor before: Ye Peng |
|
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for microbial fermentation to produce Doramycin Granted publication date: 20220311 Pledgee: Mongolian Commercial Bank Co.,Ltd. Hohhot Dazhao Branch Pledgor: INNER MONGOLIA BIOK BIOLOGY Co.,Ltd. Registration number: Y2024150000072 |